126 related articles for article (PubMed ID: 37609227)
1. A genotype-first approach identifies high incidence of
Safonov A; Nomakuchi TT; Chao E; Horton C; Dolinsky JS; Yussuf A; Richardson M; Speare V; Li S; Bogus ZC; Bonanni M; Raper A; Kallish S; Ritchie MD; ; ; Nathanson KL; Drivas TG
medRxiv; 2023 Aug; ():. PubMed ID: 37609227
[TBL] [Abstract][Full Text] [Related]
2. Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the
Smeijers S; Brems H; Verhaeghe A; van Paesschen W; van Loon J; Van der Auweraer S; Sciot R; Thal DR; Lagae L; Legius E; Theys T
J Med Genet; 2024 Jun; ():. PubMed ID: 38825366
[TBL] [Abstract][Full Text] [Related]
3. Clinical Presentation and Novel Pathogenic Variants among 68 Chinese Neurofibromatosis 1 Children.
Yao R; Yu T; Xu Y; Yu L; Wang J; Wang X; Wang J; Shen Y
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31717729
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 families with first-degree relatives harbouring distinct
Garcia B; Catasus N; Ros A; Rosas I; Negro A; Guerrero-Murillo M; Valero AM; Duat-Rodriguez A; Becerra JL; Bonache S; Lázaro Garcia C; Comas C; Bielsa I; Serra E; Hernández-Chico C; Martin Y; Castellanos E; Blanco I
J Med Genet; 2022 Oct; 59(10):1017-1023. PubMed ID: 35121649
[TBL] [Abstract][Full Text] [Related]
5. Five novel NF1 gene pathogenic variants in 10 different Chinese families with neurofibromatosis type 1.
Chen L; Xue F; Xu J; He J; Fu W; Zhang Z; Kang Q
Mol Genet Genomic Med; 2019 Sep; 7(9):e904. PubMed ID: 31347283
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.
Zhu G; Zheng Y; Liu Y; Yan A; Hu Z; Yang Y; Xiang S; Li L; Chen W; Peng Y; Zhong N; Mei H
Orphanet J Rare Dis; 2019 Sep; 14(1):221. PubMed ID: 31533797
[TBL] [Abstract][Full Text] [Related]
7. Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I.
Riva M; Martorana D; Uliana V; Caleffi E; Boschi E; Garavelli L; Ponti G; Sangiorgi L; Graziano C; Bigoni S; Rocchetti LM; Madeo S; Soli F; Grosso E; Carli D; Goldoni M; Pisani F; Percesepe A
Genes Chromosomes Cancer; 2022 Jan; 61(1):10-21. PubMed ID: 34427956
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations.
Peduto C; Zanobio M; Nigro V; Perrotta S; Piluso G; Santoro C
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831560
[TBL] [Abstract][Full Text] [Related]
9. Mutational Spectrum and Genotype-phenotype Correlations in Neurofibromatosis Type 1 Patients from North Macedonia: Identification of Ten Novel
Gjorgjievska M; Bozhinovski G; Sukarova-Angelovska E; Kocova M; Kanzoska LM; Plaseska-Karanfilska D
Balkan Med J; 2023 Jul; 40(4):252-261. PubMed ID: 37073110
[TBL] [Abstract][Full Text] [Related]
10. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II.
Koczkowska M; Chen Y; Xie J; Callens T; Gomes A; Wimmer K; Messiaen LM
Hum Genet; 2023 Jul; 142(7):849-861. PubMed ID: 37186028
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.
Koster R; Brandão RD; Tserpelis D; van Roozendaal CEP; van Oosterhoud CN; Claes KBM; Paulussen ADC; Sinnema M; Vreeburg M; van der Schoot V; Stumpel CTRM; Broen MPG; Spruijt L; Jongmans MCJ; Lesnik Oberstein SAJ; Plomp AS; Misra-Isrie M; Duijkers FA; Louwers MJ; Szklarczyk R; Derks KWJ; Brunner HG; van den Wijngaard A; van Geel M; Blok MJ
NPJ Genom Med; 2021 Nov; 6(1):95. PubMed ID: 34782607
[TBL] [Abstract][Full Text] [Related]
13. Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings.
D'Amico A; Rosano C; Pannone L; Pinna V; Assunto A; Motta M; Ugga L; Daniele P; Mandile R; Mariniello L; Siano MA; Santoro C; Piluso G; Martinelli S; Strisciuglio P; De Luca A; Tartaglia M; Melis D
Clin Genet; 2021 Nov; 100(5):563-572. PubMed ID: 34346503
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical
Büki G; Zsigmond A; Czakó M; Szalai R; Antal G; Farkas V; Fekete G; Nagy D; Széll M; Tihanyi M; Melegh B; Hadzsiev K; Bene J
Front Genet; 2021; 12():673025. PubMed ID: 34168676
[TBL] [Abstract][Full Text] [Related]
15. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1.
Rasmussen SA; Colman SD; Ho VT; Abernathy CR; Arn PH; Weiss L; Schwartz C; Saul RA; Wallace MR
J Med Genet; 1998 Jun; 35(6):468-71. PubMed ID: 9643287
[TBL] [Abstract][Full Text] [Related]
16. Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.
Alesi V; Lepri FR; Dentici ML; Genovese S; Sallicandro E; Bejo K; Dallapiccola B; Capolino R; Novelli A; Digilio MC
Eur J Hum Genet; 2022 Nov; 30(11):1239-1243. PubMed ID: 35879407
[TBL] [Abstract][Full Text] [Related]
17. Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1.
Courtney E; Chan SH; Li ST; Ishak D; Merchant K; Shaw T; Chay WY; Chin FHX; Wong WL; Wong A; Ngeow J
Fam Cancer; 2020 Oct; 19(4):353-358. PubMed ID: 32405727
[TBL] [Abstract][Full Text] [Related]
18. Implications of mosaicism in variant interpretation: A case of a de novo homozygous NF1 variant.
Alghamdi M; Monies D; Alsohime F; Temsah H; Almodaihsh F; Aldawasri M; Alsultan A; Alkuraya FS
Eur J Med Genet; 2021 Jul; 64(7):104236. PubMed ID: 33965620
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1.
Tanito K; Ota A; Kamide R; Nakagawa H; Niimura M
J Dermatol; 2014 Aug; 41(8):724-8. PubMed ID: 25041723
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1: Expanded variant spectrum with multiplex ligation-dependent probe amplification and genotype-phenotype correlation in 138 Turkish patients.
Güneş N; Yeşil G; Geyik F; Kasap B; Celkan T; Kebudi R; Tüysüz B
Ann Hum Genet; 2021 Sep; 85(5):155-165. PubMed ID: 33877690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
